U.S. markets closed

Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
128.36+4.25 (+3.42%)
At close: 4:00PM EST

128.36 0.00 (0.00%)
After hours: 4:02PM EST

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
http://www.medpace.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees3,400

Key Executives

NameTitlePayExercisedYear Born
Dr. August James TroendleChairman, Pres & CEO592.56kN/A1956
Mr. Jesse J. GeigerCFO & COO of Laboratory Operations418.98k2.2M1974
Ms. Susan E. BurwigExec. VP of Operations633.22kN/A1963
Mr. Stephen P. EwaldChief Compliance Officer, Gen. Counsel & Corp. Sec.415.79k318k1969
Mr. Todd MeyersVP of Bus. Devel. & MarketingN/AN/AN/A
Mr. Weimin Gai MSSr. VP of BiometricsN/AN/AN/A
Mr. Daniel O'LearySr. VP of Medical DepartmentN/AN/AN/A
John T. WynneSr. VP of Commercial Operations & Clinical Pharmacology UnitN/AN/AN/A
Mr. Kevin M. BradyExec. Director of Fin.N/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.

Corporate Governance

Medpace Holdings, Inc.’s ISS Governance QualityScore as of November 1, 2019 is 10. The pillar scores are Audit: 3; Board: 10; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.